arrow
P

Philippe Reix

Université de Lyon
H指数:33
被引数:4,225

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

International Delphi consensus recommendations for the follow-up of children born to people with CF and exposed to CFTR modulators in utero or through breastfeeding; endorsed by the European Cystic Fibrosis Society

欧洲囊性纤维化学会认可的关于CFTR调节剂宫内或母乳喂养暴露的CF患儿随访国际德尔菲共识建议

2026-04-270
OAAI
Beyond Trikafta: new models to assess tissue dependent rescue of N1303K-CFTR

超越Trikafta:评估组织依赖性N1303K-CFTR挽救的新模型

2025-10-290
OAAI
Effect of elexacaftor–tezacaftor–ivacaftor on bronchial dilatations in adolescents with cystic fibrosis: a multicentre prospective observational study

elexacaftor–tezacaftor–ivacaftor对囊性纤维化青少年支气管扩张的影响:一项多中心前瞻性观察性研究

2025-10-220
PRE
Molecular Investigation in Early-Onset Interstitial Lung Disease: Results From 699 Unrelated Patients

早期发病间质性肺病的分子研究:699例无关患者的结果

2025-10-030
OAAI
Sweat chloride and lung function responses to elexacaftor–tezacaftor–ivacaftor in people with cystic fibrosis with two versus one responsive CFTR variants: an analysis of two real-world observational studies

汗氯和肺功能对含elexacaftor–tezacaftor–ivacaftor的疗法在携带两种与一种应答型CFTR变异的囊性纤维化患者中的反应:两项真实世界观察性研究的分析

2025-09-030
PRE
First real-world study of fetal therapy with CFTR modulators in cystic fibrosis: Report from the MODUL-CF study

囊性纤维化中胎儿疗法使用CFTR调节剂的首项真实世界研究:MODUL-CF研究报告

2025-03-240
PRE
The expanded French compassionate programme for elexacaftor-tezacaftor-ivacaftor use in people with cystic fibrosis without a F508del CFTR variant: a real-world study
2024-11-012
PRE
A BEAT-PCD ERS CRC consensus statement for routine blood testing in primary ciliary dyskinesia in collaboration with PCD-Clinical Trial Network

与PCD合作的原发性纤毛运动障碍常规血液检测的BEAT-PCD ERS CRC共识声明-临床试验网络

2024-10-300
PRE
Epidemiology of childhood interstitial lung disease in France: the RespiRare cohort

法国儿童间质性肺疾病的流行病学: RespiRare队列

THORAX
IF7.7
2024-07-042
PRE
COBRAPed cohort: Do sensitization patterns differentiate children with severe asthma from those with a milder disease?
2024-03-225
OA
Nonsense mutations accelerate lung disease and decrease survival of cystic fibrosis children
2023-11-011
PRE